CroiValve

CroíValve is an early-stage medical device company founded in 2016 and based in Ireland. The company is focused on treating heart valve disease and is currently developing a unique transcatheter device to repair the tricuspid valve. Their most recent milestone includes securing a Series B investment on August 7, 2024. This notable achievement indicates a growing interest and confidence from investors in CroíValve's innovative approach to addressing heart valve disease. With this investment, the company has the potential to further advance the development and potential commercialization of its transcatheter device. This not only signifies a significant financial backing, but also validates the potential impact of CroíValve's technology in the medical field. As they continue to progress and attract investment, CroíValve is poised to make significant strides in revolutionizing the treatment of tricuspid valve issues, ultimately bringing about positive change in the medical devices and cardiovascular health industries.